Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04358913

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Led by AHS Cancer Control Alberta · Updated on 2025-05-14

250

Participants Needed

1

Research Sites

384 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cancers are often treated with external beam radiotherapy. Current radiotherapy treatments are performed using computed tomography (also known as CT) scans which may not always clearly identify the cancer. In some instances, magnetic resonance imaging (MRI) may be able to better identify cancers. Therefore, efforts are currently underway to use the MRI scans to improve radiotherapy treatments or eventually even use radiotherapy equipment that only uses MRI scans to guide treatments. This new technology that will only use MRI scans to guide treatments is called the Linac-MR (linear accelerator with an MRI). The purpose of this pilot phase of the study is to test whether the Alberta linac-MR P3 system at the Cross Cancer Institute can acquire high quality MR images safely. It will allow the researchers to develop the best collection of MR images possible with this new machine, in order to allow them to visualize tumors for future patients that are treated on this machine.

CONDITIONS

Official Title

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years of age or older
  • Patients deemed fit to undergo high dose external beam radiation therapy by their attending radiation oncologist
Not Eligible

You will not qualify if you...

  • Patients with contraindications for MRI
  • Patients unable to lie flat and still for the duration of the expected scan
  • Patients unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cross Cancer Institute

Edmonton, Alberta, Canada, T6G 1Z2

Actively Recruiting

Loading map...

Research Team

N

Nawaid Usmani, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DEVICE_FEASIBILITY

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here